BACKGROUND GUIDE
UNITED NATIONS OFFICE
ON DRUGS AND CRIME
AGENDA
Reevaluating Global Drug Policies in the Era of Evolving
Science, Digital Realities, and Medical Discoveries
CHIREC MUN' 23
Represent • Reason • Resolve
EXECUTIVE BOARD
Greetings Delegates!
The Executive Board of the United Nations Office on Drugs and Crime
takes this opportunity to extend a warm hand of gratitude to the
participants and requests everyone to use this document as a basis for
their research. Please remember that this document is just a framework
for more profound research. This document consists of readings from
various sources, and we have attempted to make it as comprehensive
as possible.
We are following the UNA-USA Rules of Procedure (RoP) in the
committee, which looks for consensus-building rather than conflicting
and adverse debate.
Please contact any of us for any clarifications regarding the document.
Serendeep Rudraraju
Chairperson
[email protected]
CHIREC MUN' 23
Represent • Reason • Resolve 01
THE UNITED NATIONS OFFICE ON DRUGS
AND CRIME (UNODC):
A. Origins and Establishment
Founded in 1997, the UNODC emerged from a merger of the United Nations
Drug Control Programme and the Crime Prevention and Criminal Justice
Division. Its creation signified a unified commitment to addressing the
intertwined challenges of illicit drugs and international crime.
B. Mandate & Mission:
The UNODC is charged with the formidable task of assisting member states
in addressing and mitigating the multifaceted challenges presented by illicit
drugs, transnational organized crime, corruption, and terrorism. It aims to
foster international cooperation, provide practical solutions, and promote a
balanced and holistic approach that interlinks prevention, prosecution, and
health.
C. Operational Footprint:
With field offices spread globally, the UNODC offers hands-on technical
assistance, facilitates capacity-building initiatives, and drives research and
analytical work to inform policy-making.
D. Strategic Priorities:
1. Health & Livelihoods: Advocating for evidence-based drug prevention,
treatment, rehabilitation, and HIV services.
2. Rule of Law: Assisting countries in drafting laws, creating comprehensive
crime prevention strategies, and strengthening the justice sector.
3. Research & Threat Analysis: Drawing insights from data to shape
international responses through publications such as the World Drug
Report.
CHIREC MUN' 23
Represent • Reason • Resolve 02
THE COMMISSION ON NARCOTIC
DRUGS (CND):
Historical Backdrop:
In the wake of World War II, as the world sought to create a new international
order, the United Nations Economic and Social Council (ECOSOC) established the
CND in 1946. The commission was to become the primary policymaking body on
drug-related issues within the United Nations framework.
Mandate & Role:
As the principal policy-setting entity on global drug matters, the CND is tasked
with forging international strategies, overseeing the implementation of the three
primary international drug control conventions, and addressing emerging
challenges.
Responsibilities in Focus:
1. Policy Development: Drafting and refining international drug control
conventions, which act as the bedrock of global narcotics and psychotropic
substance regulations.
2. Review & Analysis: An annual examination of the global drug situation,
understanding trends, challenges, and the effectiveness of existing
strategies.
3. Control & Scheduling: Based on scientific and medical evaluations, the CND
decides on control measures for narcotics and psychotropic substances.
4. Promotion of International Cooperation: Fostering dialogue and collaboration
between member states, ensuring the harmonization of efforts.
The Symbiotic Relationship:
While distinct in their roles, the UNODC and CND are intricately connected. The
CND, with its policymaking capabilities, crafts the overarching strategies and
guidelines. In tandem, the UNODC, with its operational outreach, works on the
ground, ensuring that these strategies are translated into actionable initiatives,
fostering real-world impact. Together, they embody the global commitment to
creating a world free from the challenges posed by illicit drugs and crime.
CHIREC MUN' 23
Represent • Reason • Resolve 03
"RE-EVALUATING GLOBAL DRUG POLICIES IN THE ERA OF
EVOLVING SCIENCE, DIGITAL REALITIES, AND MEDICAL
DISCOVERIES"
I. Introduction
In a rapidly changing global landscape, traditional approaches to drug policy
have been thrust under the spotlight. The interplay of emerging scientific
research, digital advancements, and novel medical discoveries demands a
reevaluation of the frameworks that have long governed international
narcotics and psychotropic substance regulations. As countries grapple with
the complexities of this new era, the overarching question remains: How can
global drug policies evolve to reflect the realities of our time while ensuring
societal health and safety?
II. Psychedelic Renaissance: Rethinking Drug Classifications
Historical Context:
Psychedelics, once the subject of rigorous scientific investigation in the
1950s and 60s, faced worldwide prohibition due to socio-political factors.
Compounds like LSD and psilocybin were widely criminalized, stifling
research and therapeutic exploration.
Modern Renaissance:
Recent years have seen a revival of interest in psychedelics. Preliminary
studies indicate potential therapeutic benefits in treating conditions like
PTSD, depression, and addiction. As a result, some nations are reconsidering
their stance on these substances, prompting discussions on their
reclassification.
CHIREC MUN' 23
Represent • Reason • Resolve 04
Current Research:
Various studies are exploring psychedelics like psilocybin, LSD, and MDMA
for their potential therapeutic benefits. Clinical trials are assessing their
effectiveness in treating conditions such as PTSD, depression, anxiety,
and substance abuse. Prominent research includes the work of
organizations like MAPS (Multidisciplinary Association for Psychedelic
Studies) and studies conducted by leading universities.
Legal Implications:
The renewed interest in psychedelics for therapeutic purposes is leading
to legal reforms in some jurisdictions. This includes the decriminalization
of certain substances and the approval of their use in controlled, clinical
settings. However, there's a complex legal landscape due to international
treaties like the Single Convention on Narcotic Drugs, which classify
many psychedelics as Schedule I substances.
Challenges and Considerations:
Evaluating the balance between potential medical benefits and
societal risks.
Navigating the regulatory path for medical use while preventing
recreational misuse.
Ensuring equitable access and avoiding commercial exploitation.
Reference: UNODC - The Single Convention on Narcotic Drugs, 1961
CHIREC MUN' 23
Represent • Reason • Resolve 05
III. Navigating the Digital Frontier: Online Drug Markets vs. Internet
Freedoms
The Digital Marketplace:
The advent of the digital age brought with it the dark web – an anonymized
segment of the internet where illicit drug markets flourish. Platforms such
as Silk Road have showcased the potential reach and scale of online drug
distribution.
Technology as an Ally:
Conversely, digital advancements offer tools for drug policy enforcement.
Blockchain can trace drug supply chains, and AI can analyze vast online
data to detect illicit activities.
Law Enforcement Strategies:
Law enforcement agencies are employing advanced digital forensics,
undercover operations, and collaborations with tech companies to combat
online drug markets. The closure of platforms like Silk Road is a testament
to these efforts. However, the rise of encrypted messaging apps and
cryptocurrencies poses ongoing challenges.
Cybersecurity Aspects:
Drug trafficking increasingly intersects with cybersecurity, as dark web
markets operate on encrypted networks. This raises issues around data
privacy, the role of internet service providers, and the need for
international cooperation in cybercrime investigation.
Challenges and Considerations:
Striking a balance between internet freedom and curbing online drug
markets.
The potential for technology to either amplify or mitigate the global
drug problem.
Addressing the jurisdictional complexities posed by the digital drug
trade.
Reference: UNODC - World Drug Report 2020
CHIREC MUN' 23
Represent • Reason • Resolve 06
IV. The Cannabis Debate: Between Medical Potential and Recreational
Use
Historical Viewpoint:
Cannabis has been used for medicinal, recreational, and industrial
purposes for centuries. However, the 20th century saw its widespread
criminalisation, driven by political, economic, and social factors.
Modern Reappraisal:
The past decade has witnessed a seismic shift in the perception of
cannabis. Numerous countries and jurisdictions have either
decriminalized or legalized its medical and/or recreational use, spurred
by evolving scientific research and societal attitudes.
Economic Impact:
Legalizing cannabis has led to significant economic benefits in regions
like Canada and some U.S. states. This includes billions of dollars in
revenue from sales taxes, job creation in cultivation, distribution, and
retail, and the growth of ancillary industries such as cannabis tech and
legal services.
Public Health Perspectives:
Public health experts have differing views on cannabis legalization. Some
highlight potential benefits like controlled quality, harm reduction, and
medicinal uses. Others raise concerns about increased usage rates,
especially among youths, potential for addiction, and long-term mental
health effects.
Challenges and Considerations:
Understanding the long-term societal impacts of cannabis
legalization.
Navigating international treaties in light of diverging national policies.
Ensuring the safe medical application of cannabis and its derivatives.
Reference: UNODC - The Convention on Psychotropic Substances, 1971
07
.
CHIREC MUN' 23
Represent • Reason • Resolve
V. Conclusion:
The global drug policy landscape is at a critical juncture, with old conventions
being challenged by new findings, societal shifts, and the realities of the
digital age. The CND, as a leading entity in this realm, has the onus of fostering
dialogue and guiding the international community towards policies that are
both progressive and pragmatic, ensuring the health and well-being of global
citizens.
Future Trends:
Technological Integration: Advances in AI and data analytics may refine
drug policy implementation and monitoring.
Global Drug Policy Reform: A shift towards harm reduction,
decriminalization, and holistic approaches to drug addiction treatment.
Societal Attitudes: Increased public awareness and changing attitudes
might lead to more progressive drug policies, especially concerning
cannabis and psychedelics.
International Cooperation: Enhanced global collaboration in addressing
the complexities of internet-facilitated drug trafficking and cybercrime.
VI. Questions to be addressed:
How can member states ensure that the potential therapeutic benefits of
psychedelics are realized while preventing misuse and commercialisation?
How can international cooperation be fostered to share research findings
and best practices regarding the therapeutic use of psychedelics?
To what extent should member states regulate or monitor the digital
sphere to combat online drug markets without infringing on individual
privacy rights?
How can the international community collaborate to address the
jurisdictional challenges posed by the digital drug trade?
How can international drug conventions adapt to the diverging national
policies on cannabis, especially considering its medicinal and recreational
aspects?
What are the potential societal and health implications of widespread
cannabis legalization? How might they be mitigated?
How can member states ensure that the medical application of cannabis is
based on rigorous scientific evidence while ensuring accessibility for
those in need?
.
CHIREC MUN' 23
Represent • Reason • Resolve 08
